Journals / Acta Medica Alanya / 2020 / Cilt: 4 - Sayı: 1

Evaluation of Tuberous Sclerosis Complex Patients

Tüberoskleroz kompleksi tanılı hastaların değerlendirilmesi

Pages
82–87
Publication Date
2022-09-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although not included in the diagnostic criteria, it should be kept in mind that epilepsy, intellectual disability and neuropsychiatric disorders frequently accompany.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Tuberous sclerosis complex (TSC) is a multisystem genetic, autosomal-dominant disorder predisposing to multiple organ manifestations.
📊
Key Findings & Data:The diagnosis of the patients were evaluated according to the diagnostic criteria of TSC that were updated in 2012.
💡
Conclusion & Impact:Although not included in the diagnostic criteria, it should be kept in mind that epilepsy, intellectual disability and neuropsychiatric disorders frequently accompany.
🔬Design:Review & Systematic Survey
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Tuberous sclerosis complex (TSC) is a multisystem genetic, autosomal-dominant disorder predisposing to multiple organ manifestations. The aim of this study is to determine TSC the frequency of findings including diagnostic and non-diagnostic criteria. Patients and Metod:Thirty-five patients diagnosed with tuberous sclerosis complex were examined retrospectively. The diagnosis of the patients were evaluated according to the diagnostic criteria of TSC that were updated in 2012. As non-diagnostic criteria, we reviewed epilepsy, drug-resistant epilepsy, electroencephalography (EEG) types (focal, diffuse-multifocal and hypsarrhythmia) and TAND (TSC-associated neuropsychiatric disorders) (intellectual disability and/or autism and learning disability). Results: Twenty-one cases (60%) presented with seizures, 9 cases (26%) with hypopigmented patches and 5 cases (14%) with cardiac rhabdomyomas. The most common finding with brain magnetic resonance imaging (MRI) was cortical tubers (85%). EEG examinations revealed diffuse and multifocal epileptic disorder in 5 (24%), focal epileptic disorder in 8 (38%), and hypsarrhythmia in 8 (38%) patients. 38% of the patients with epilepsy were diagnosed with refractory epilepsy. Severe intellectual disability and / or autism were detected in 11 (32%) patients. The number of patients with renal angiomyolipoma (p:0.001) were significantly higher in drug resistant epilepsy patients and also TSC-associated neuropsychiatric disorders (TAND) (p:0.001) rate was significantly higher in epilepsy patients. Conclusion: The disease should be followed with a multidisciplinary approach. Although not included in the diagnostic criteria, it should be kept in mind that epilepsy, intellectual disability and neuropsychiatric disorders frequently accompany.

Özet

Amaç: Tüberoskleroz kompleksi (TSK) vücutta birçok organın tutulumu ile karakterize, otozomal dominant kalıtım gösteren genetik bir rahatsızlıktır. Bu çalışmada TSK tanı kriterlerinin ve tanı kriterleri dışındaki bulguların sıklığını belirlemek amaçlanmıştır. Hastalar ve Yöntemler: TSK tanılı 35 hastanın verileri geriye dönük olarak incelendi. Hastaların tanısı, 2012 yılında güncellenen TSK'nin tanı kriterlerine göre değerlendirildi. Tanısal olmayan kriterler olarak; epilepsi, ilaca dirençli epilepsi, elektroensefalografi (EEG) tiplerini (fokal, diffüz-multifokal ve hiperaritmi) ve TAND'ı (TSC ile ilişkili nöropsikiyatrik bozukluklar) (zihinsel yetersizlik ve / veya otizm ve öğrenme yetersizliği) inceledik. Bulgular: Yirmi bir hasta (%60) nöbet geçirme, 9 hasta (%26) hipopigmente lekelenmeler ve 5 hasta (%14) kardiyak rabdomiyomlar nedeniyle başvurmuştu. Beyin magnetik rezonans görüntüleme (MRG) ile en sık saptanan bulgu kortikal tüberlerdi (%85). Nöbet geçiren hastaların EEG incelemelerinde 5’inde (%24) yaygın ve multifokal epileptik bozukluk, 8’inde (%38) fokal epileptik bozukluk ve 8’inde (%38) hipsaritmi paterni saptandı. Epilepsi tanısı ile izlenen olguların %38’i dirençli epilepsi tanısına sahipti. Ağır derecede entelektüel yetersizlik ve/veya otizm 11 (%32) hastada saptandı. Dirençli epilepsi grubunda böbrek anjiomiyolipomaları olan hasta sayısı anlamlı olarak fazlaydı (p:0.001) ve aynı zamanda tüberoskleroz ile ilişkili nöropsikiyatrik bozuklukların oranı anlamlı olarak epilepsi grubunda yüksekti (p:0.001). Sonuç: Hastalığın multidisipliner bir yaklaşım ile takip edilmesi gerekmektedir. Tanı kriterlerinde yer almasa da epilepsi, entelektüel yetersizlik ve nöropsikiyatrik bozuklukların sık eşlik ettiği akılda tutulmalıdır.

🔖

Cite This Article

Gürkaş, E., Ceylan, N., Altan, H., Güven, A., Öztürk, Z., Karalok, Z. S. (2022). Evaluation of Tuberous Sclerosis Complex Patients. Acta Medica Alanya, Cilt: 4 - Sayı: 1, 82–87. https://ajindex.com/articles/425814

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008
  2. 372(9639):657– 68. PMID:18722871 2. Hallett L, Foster T, Liu Z, Blieden M, Valentim J. Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin. 2011
  3. 27(8): 1571-83. PMID:21692602 3. Schwartz RA, Fernández G, Kotulska K et al. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol. 2007
  4. 57(2):189-202. PMID:17637444 4. Northrup H, Krueger D. International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013
  5. 49(4):243–54. PMID:24053982 5. Krueger DA, Northrup H. International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013
  6. 49(4):255–265. PMID:24053983 6. Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015
  7. 14(7):733-45. PMID:26067126 7. Holmes GL, Stafstrom CE
  8. Tuberous Sclerosis Study Group. Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia. 2007
  9. 48(4):617-30. PMID:17386056 8. Smalley SL, Burger F, Smith M. Phenotypic variation of tuberous sclerosis in a single extended kindred. J Med Genet. 1994
  10. 31(10):761-5. PMID:7837252 9. Saltık S, Karatoprak EY, Taşel B. Characteristics and the clinical course of epilepsy in patients with tuberous sclerosis complex. Türk Pediatri Arş. 2013
  11. 48(2):123-30. doi:10.4274/tpa:116 10. Józwiak S, Schwartz RA, Janniger CK,Michałowicz R, Chmielik J. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol. 1998
  12. 37(12):911-7. PMID:9888331 11. Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, Delgado MR et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med. 2007
  13. 9(2):88-100. PMID:17304050 12. Mettin RR, Merkenschlager A, Bernhard MK, Elix H, Hirsch W, Kiess W et al. Wide spectrum of clinical manifestations in children with tuberous sclerosis complex–Follow-up of 20 children. Brain Dev. 2014
  14. 36(4):306-14. PMID:23751858 13. Chu-Shore CJ